Document is current
Any future updates will be listed below
-
Authors
Ghafoori, Parima
Patel, Dharm S.
Raymond, Kimberly
Brennan, Elizabeth
Foster, April Mitchell
Jackson, Kristi
Birch, Helen J.
Chen, Wen-Hung
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 21 March 2025
First Online: 10 April 2025
Declarations
:
: Ethics approval for the qualitative study was granted by WIRB-Copernicus Group (WCG) (approval number: 36561371.0; granted: 25 February 2023). WCG reviewed and approved all qualitative study materials prior to the start of recruitment. Following determination of eligibility, each participant was asked to review, complete, and return the informed consent form before their scheduled interview.
: Non applicable.
: Data from this study were previously presented as poster presentations at Fall Clinical Dermatology Conference 2023, and the American Academy of Dermatology Annual Meeting (AAD), 2024.
: DSP, and HJB are employees of GSK and hold financial equities in GSK. KR, AMF, KJ, and EB are employees of QualityMetric Incorporated. PG and W-HC were employees of GSK at the time of the study and hold financial equities in GSK. GSK contracted and funded QualityMetric Incorporated to conduct this study.
